The biopharmaceutical industry is experiencing a profound transformation, marked by a wave of layoffs and strategic overhauls across companies of all sizes. Confronted with economic headwinds and the urgency to adapt, biopharma entities are taking decisive steps to shore up their operations. This
The pharmaceutical industry confronts a pivotal moment as the imperative to integrate sustainability throughout supply chains gains momentum. Amid shifting paradigms, companies are increasingly aware that business success is no longer measured solely in financial terms. Today's corporate climate
In a significant expansion of its life sciences portfolio, global science and technology leader Merck has announced a definitive agreement to purchase Mirus Bio for a staggering $600 million. Mirus Bio, a pioneering life sciences company, specializes in developing transfection reagents, a
In a strategic move blending technological innovation with environmental consciousness, SGD Pharma has invested over €20 million to advance its facility in Zhanjiang, China. This significant refurbishment is not merely about upgrading the equipment but is part of a greener manifesto—committing to
In the ever-evolving landscape of pharmaceuticals, the debate over regulatory data protection (RDP) is intensifying. As the Belgian Presidency of the Council of the EU approaches its twilight, policymakers are grappling with how to balance the imperatives of fostering pharmaceutical innovation with
The landscape of biopharmaceutical manufacturing in Ireland has recently welcomed an impressive addition with the inauguration of the National Institute for Bioprocessing Research and Training's (NIBRT) new facility. This state-of-the-art establishment in Dublin, conceived with a robust €21 million
